Creative Planning Abb Vie Inc. Transaction History

Creative Planning

$101 Billion
Q3 2024

A detailed history of Creative Planning transactions in Abb Vie Inc. stock. As of the latest transaction made, Creative Planning holds 750,811 shares of ABBV stock, worth $135 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

750,811

Previous 717,586 4.63%

Holding current value

$135 Million

Previous $123 Million 20.47%

% of portfolio

0.15%

Previous 0.13%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 11, 2024	BUY	$163.84 - $199.33 $5.44 Million - $6.62 Million	33,225 Added 4.63%	750,811 $148 Million
Q2 2024 Aug 15, 2024	BUY	$154.79 - $180.76 $431,399 - $503,778	2,787 Added 0.39%	717,586 $123 Million
Q1 2024 May 10, 2024	BUY	$159.82 - $182.1 $5.03 Million - $5.73 Million	31,489 Added 4.61%	714,799 $130 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $2.47 Million - $2.79 Million	17,978 Added 2.7%	683,310 $106 Million
Q3 2023 Nov 16, 2023	BUY	$133.59 - $154.65 $7.32 Million - $8.48 Million	54,826 Added 8.98%	665,332 $99.2 Million
Q2 2023 Jul 21, 2023	BUY	$132.51 - $164.9 $166,167 - $206,784	1,254 Added 0.21%	610,506 $82.3 Million
Q1 2023 May 15, 2023	BUY	$144.61 - $166.54 $2.38 Million - $2.74 Million	16,426 Added 2.77%	609,252 $97.1 Million
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $18.6 Million - $22.2 Million	134,121 Added 29.24%	592,826 $95.9 Million
Q3 2022 Nov 03, 2022	BUY	$134.21 - $153.93 $326,532 - $374,511	2,433 Added 0.53%	458,705 $61.6 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $3.43 Million - $4.36 Million	24,906 Added 5.77%	456,272 $69.9 Million
Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $3.06 Million - $3.79 Million	23,152 Added 5.67%	431,366 $69.9 Million
Q4 2021 Feb 11, 2022	BUY	$107.43 - $135.93 $1.12 Million - $1.41 Million	10,382 Added 2.61%	408,214 $55.3 Million
Q3 2021 Nov 10, 2021	BUY	$106.4 - $120.78 $440,815 - $500,391	4,143 Added 1.05%	397,832 $42.9 Million
Q2 2021 Aug 04, 2021	SELL	$105.21 - $117.21 $5.76 Million - $6.41 Million	-54,720 Reduced 12.2%	393,689 $44.3 Million
Q1 2021 Apr 30, 2021	BUY	$102.3 - $112.62 $910,879 - $1 Million	8,904 Added 2.03%	448,409 $48.5 Million
Q4 2020 Jan 29, 2021	BUY	$80.49 - $108.67 $1.48 Million - $1.99 Million	18,327 Added 4.35%	439,505 $47.1 Million
Q3 2020 Nov 05, 2020	BUY	$85.91 - $100.83 $3.04 Million - $3.57 Million	35,371 Added 9.17%	421,178 $36.9 Million
Q2 2020 Jul 23, 2020	BUY	$73.37 - $98.18 $2.2 Million - $2.95 Million	30,050 Added 8.45%	385,807 $37.9 Million
Q1 2020 May 05, 2020	SELL	$64.5 - $97.79 $636,808 - $965,480	-9,873 Reduced 2.7%	355,757 $27.1 Million
Q4 2019 Jan 30, 2020	SELL	$72.13 - $90.25 $558,430 - $698,715	-7,742 Reduced 2.07%	365,630 $32.4 Million
Q3 2019 Nov 01, 2019	SELL	$62.98 - $75.72 $153,104 - $184,075	-2,431 Reduced 0.65%	373,372 $28.3 Million
Q2 2019 Jul 26, 2019	BUY	$65.7 - $83.98 $2.59 Million - $3.31 Million	39,427 Added 11.72%	375,803 $27.3 Million
Q1 2019 Apr 24, 2019	BUY	$77.14 - $90.79 $1.6 Million - $1.88 Million	20,721 Added 6.56%	336,376 $27.1 Million
Q4 2018 Feb 01, 2019	BUY	$77.85 - $96.01 $1.08 Million - $1.34 Million	13,932 Added 4.62%	315,655 $29.1 Million
Q3 2018 Oct 25, 2018	BUY	$88.91 - $98.84 $1.4 Million - $1.55 Million	15,702 Added 5.49%	301,723 $28.5 Million
Q2 2018 Jul 20, 2018	BUY	$89.78 - $106.23 $1.65 Million - $1.95 Million	18,377 Added 6.87%	286,021 $26.5 Million
Q1 2018 Apr 18, 2018	BUY	$92.01 - $123.21 $599,997 - $803,452	6,521 Added 2.5%	267,644 $25.3 Million
Q4 2017 Jan 17, 2018	BUY	$89.56 - $98.21 $1.93 Million - $2.12 Million	21,549 Added 8.99%	261,123 $25.3 Million
Q3 2017 Oct 17, 2017	BUY	$69.85 - $89.22 $16.7 Million - $21.4 Million	239,574	239,574 $21.3 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

News

Stay updated on Creative Planning with notifications on news.

Account

Creative Planning Abb Vie Inc. Transaction History